Senior insider sale
Chief Financial Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$2.52M
37.50K shares
What this filing means
BURROWS SCOTT L plans to sell 37.50K shares of SPYRE THERAPEUTICS, INC. valued at approximately $2.52M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/1/2026ACC: 0001950047-26-003922
Officer· Chief Financial Officer
Since Mar 2026
37.50K
Shares to sell
$2.52M
Approx. market value
27.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/1/2026
27.50KTotal acquired27.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2026 | Exercise of Stock Options Cash | 27.50K | — |
| Total | 27.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.50K
Market value
$370.1K
4/1/2026
—Completed
Units to sell
2.50K
Market value
$101.6K
3/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
27.50K
Market value
$2.05M
5/1/2026
Total
Units
37.50K
Value
$2.52M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 7.50K | $370.1K | — | Completed |
3/3/2026 | 2.50K | $101.6K | — | Completed |
| Planned — Approximate Date | ||||
5/1/2026 | 27.50K | $2.05M | NASDAQ | Planned |
| Total | 37.50K | $2.52M | ||